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Abstract
Background & Aim—Steatohepatitis (SH) is associated with mitochondrial dysfunction and
superoxide overgeneration, which can be converted into H2O2 by SOD2. Since mitochondrial
GSH (mGSH) plays a critical role in H2O2 reduction, we explored the interplay between
superoxide, H2O2 and mGSH in nutritional and genetic models of SH, which exhibit mGSH
depletion.
Methods—Isolated mitochondria and primary hepatocytes, as well as in vivo SH models
showing mGSH depletion to test the consequences of superoxide scavenging.
Results—In isolated mitochondria and primary hepatocytes superoxide scavenging by SOD
mimetics or purified SOD decreased superoxide and peroxynitrite generation but increased H2O2
following mGSH depletion despite mitochondrial peroxiredoxin/thioredoxin defense. Selective
mGSH depletion sensitized hepatocytes to cell death induced by SOD mimetics and this was
prevented by RIP1 kinase inhibition with necrostatin-1 or GSH repletion with GSH ethyl ester
(GSHee). Mice fed the methinonie-choline deficient (MCD) diet or MAT1A−/− mice exhibit
reduced SOD2 activity; in vivo treatment with SOD mimetics increased liver damage,
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inflammation, and fibrosis, despite decreased superoxide and 3-nitrotyrosine immunoreactivity,
effects that were ameliorated by mGSH replenishment with GSHee but not NAC. As a proof-of-
principle of the detrimental role of superoxide scavenging in the face of mGSH depletion,
transgenic mice overexpressing SOD2 exhibited enhanced susceptibility to MCD-mediated SH.
Conclusion—These findings underscore a critical role for mGSH in the therapeutic potential of
superoxide scavenging in SH, and suggest that the combined approach of superoxide scavenging
with mGSH replenishment may be of significance in SH.
INTRODUCTION
Steatohepatitis (SH) is an intermediate stage of alcoholic (ASH) and nonalcoholic
steatohepatitis (NASH), which can further progress to cirrhosis and hepatocellular
carcinoma. Predominant etiology includes alcohol drinking or insulin resistance/type II
diabetes. Despite intense research ASH/NASH pathogenesis is still poorly understood [1].
Mitochondrial dysfunction and oxidative stress are critical players, taking a central stage in
the “two-hits” scenario of SH [2]. Although other potential mechanisms contribute to
disease progression (e.g. endoplasmic reticulum stress), NASH is considered a
mitochondrial disease [3]. Due to the rising prevalence of obesity worldwide NASH
constitutes a global health concern requiring the urgent need for more effective therapies.
Mitochondria are the primary intracellular sites of oxygen consumption and the major
source of reactive oxygen species (ROS) generation is the mitochondrial respiratory chain
(MRC) [4]. Patients with NASH exhibit defective MRC [5], and increased mitochondrial
generation of superoxide has been shown in ASH/NASH models [6, 7]. In addition to its
own damaging reactivity with iron-sulfur centers, the superoxide can be the source of further
ROS and reactive nitrogen species (RNS). Superoxide can interact with nitric oxide (NO) to
produce the highly reactive product peroxynitrite, which has a short half-life and is
responsible for many damaging modifications of tyrosine residues in mitochondrial target
proteins [8]. The elimination of mitochondrial superoxide by SOD2 is essential in the
defense against oxidative stress and SOD2 deficiency leads to neonatal death in mice. The
dismutation of superoxide generates H2O2, a potent oxidant. The degradation of
mitochondrial H2O2 is carried out by the antioxidant enzymes GSH peroxidase 1 (GSHPx1)
and peroxiredoxin-III (Prx-III), the former of which requires GSH for its activity. Prx-III
reactivation upon reduction of H2O2 occurs by thioredoxin-2 (Trx2). The status of SOD2 in
SH is not well established with studies indicating either decreased or no changes in
expression [9, 10]. Moreover, mitochondrial GSH (mGSH) depletion has been reported in
both ASH/NASH models [7] as well as in human NASH [11].
Given the role of superoxide in pathogenesis, its scavenging may be of significance in
diverse diseases. To overcome the problems associated with the use of the native SOD
enzymes, such as their inaccessibility to intracellular compartments and adverse effects due
to immunogenic responses, chemical SOD mimetics have been developed and characterized
for SOD activity [12] and shown in vivo therapeutic potential against a wide range of
diseases [13]. However, studies using SOD mimetics in SH are scarce, and the interplay
between superoxide scavenging, H2O2 and mGSH in disease progression has not been
specifically examined. Thus, we addressed the role of mGSH in controlling the therapeutic
potential of superoxide scavenging in nutritional and genetic NASH models namely,
MAT1A knockout mice [14] and mice fed methionine-choline deficient (MCD) diet [15],
which exhibit mGSH depletion [16]. Our findings indicate that SH is characterized by the
impairment of both SOD2 and mGSH defense. However, the beneficial effect of superoxide
scavenging is determined by mGSH, and hence their combination may be of relevance in
SH.
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MATERIALS AND METHODS
Animals, mitochondria isolation and treatments
Male mice (C57BL/6J, 8 wks) (Charles River Laboratories) were housed in a pathogen-free
barrier facility and the protocols approved by the IDIBAPS Animal Care Committee. Mice
were fed MCD diet (or the corresponding control diet supplemented with methionine and
choline), alcohol liquid diet (intragastrically or orally for 1–12 months) as described [17,
18], or a high fat diet (60% of the KCal derived from fat, Research Diets) for 16–20 weeks.
TgSOD2 mice have been characterized before [19] and expressed 2–3 fold SOD2 levels
compared to wild type mice. Rat liver mitochondria were isolated as described previously
[20], and mitochondrial purity was assessed by determination of succinic dehydrogenase,
lactic dehydrogenase and the presence of microsomes (GRP78/Bip), plasma membrane (Na
+/K+ ATPase), endosomes (Rab5A/Rab11) and lysosomes (Lamp1). In addition, we
monitored the acceptor control ratio (ACR) as a measure of mitochondrial quality.
Furthermore, isolated mitochondria and hepatocytes were prepared from mice fed MCD or
MAT1A null mice to determine the generation of superoxide and hydrogen peroxide and
cell death. In other experiments superoxide anion was generated in isolated mitochondria by
xanthine/xanthine oxidase (X/XO, 0.1mM/20U/ml), glucose/glucose oxidase (G/GO,
0.1mM/20U/ml) in the presence or absence of MnTBAP (50 M), CuDIPS (50 M) or purified
SOD from bovine erythrocytes (Sigma) with or without mGSH depletion. mGSH depletion
in isolated mitochondria was induced by ethacrinic acid (EA, 250 M) or diethylmaleate
(DEM, 0.8mM) and with 3-hydroxy-4-pentenoate (HP, 1mM) in hepatocytes as described
(20). In some cases, hepatocytes were incubated with necrostatin-1 (20 M), caspase inhibitor
I (Calbiochem, 50 M), desferoxamine (0.5mg/ml) or catalase (200U/ml) to determine cell
viability.
ROS/RNS determination
ROS determination was measured by MitoSOX (5 µM, Molecular Probes) or Amplex Red
Hydrogen peroxide/Peroxidase Assay Kit (1 M, Invitrogen) as described before [21] and
detailed in Supplemental Methods. In some cases, mitochondria were incubated with the
nitric oxide donor Deta NoNoate and peroxynitrite was determined using the specific probe
APF (5 M, Molecular Probes) which does not monitor NO, superoxide or hydrogen peroxide
[22].
In vivo effects of SOD mimics in nutritional and genetic NASH models
Mice were fed a MCD diet (2–15 days) with or without MnTBAP treatment (10 g/kg, ip) for
2 days. In addition, MAT1A null mice (3 and 9 months old) or corresponding wild type
mice were treated with MnTBAP for 2 days. Serum and liver samples were processed for
ALT and H&E staining. Inflammatory cell infiltration was examined by myeloperoxidase
staining, and Sirius red staining was used to monitor fibrosis. In some cases, MCD-fed mice
were co-treated with GSHee, NAC or necrostatin-1 to evaluate the course of liver damage
induced by superoxide scavenging with MnTBAP. Lipid peroxidation was assessed as the
presence of carbonyl proteins determined by immunoblotting as described before [23]. In
addition, in some cases MCD-fed mice were treated with the mitochondrial targeted
antioxidant MitoQ or its inactive analogue decylT
Statistical analyses
Results are reported as means ± SD. Student’s t-test or ANOVA with Bonferroni’s post-hoc
test or Mann-Whitney Rank Sum test was used for the determination of statistical
significance among treatment groups, as appropriate.
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RESULTS
Mitochondrial superoxide scavenging increases H2O2 following GSH depletion despite
Prx-III/Trx2 defense
To test the hypothesis that GSH is critical for the fate of H2O2 derived from superoxide
scavenging, we examined their interplay in isolated mitochondria with or without GSH
depletion using well-characterized electrophiles. EA depleted mitochondrial GSH levels by
70–80% (Figure 1A). To mimic the superoxide generation occurring in SH, X/XO was used
to increase superoxide anion and H2O2 (Figure 1B, C). The addition of the SOD mimetic
MnTBAP significantly decreased superoxide formation by X/XO, leading to a slight
increase in H2O2 levels (Figure 1B, C). MnTBAP alone, however, did not increase the basal
levels of superoxide, eliminating a direct role for the SOD mimetic in ethidium oxidation.
To validate the effects of MnTBAP on superoxide scavenging, we used purified SOD from
bovine erythocytes, which recapitulated the effects on superoxide and H2O2 induced by
MnTBAP (Supplementary Figure 1A, 1B). However, in mitochondria that have been GSH-
depleted by EA treatment, MnTBAP caused opposite quantitative changes, decreasing
superoxide but increasing hydrogen peroxide following X/XO exposure (Figure 1C). The
addition of exogenous catalase abolished the increase of H2O2 stimulated by MnTBAP in
GSH depleted mitochondria (Figure 1C). Similar findings were observed when GSH was
depleted in isolated mitochondria by DEM (Supplementary Figure 2A, B) or after in vivo
treatment with buthionine sulfoximine (not shown). Moreover, similar to mitochondria
exposed to X/XO increased superoxide anion and hydrogen peroxide levels were observed
in isolated mitochondria from mice fed MCD compared to mitochondria from control mice
fed methionine and choline supplemented diet (Supplementary Figure 3).
In addition to GSH, Prx-III also plays a key role in controlling the levels of mitochondrial
H2O2 [7]. We monitored the redox status of Prx-III in isolated mitochondria with or without
AMS, which modifies reduced protein thiols [24]. Compared to tert-butylhydroperoxide
treatment, Prx-III remained in the reduced state despite GSH depletion by EA as seen by the
slower migration induced by AMS compared to oxidized form (Figure 1D). Trx2 activity
(Supplementary Figure 4A) remained unchanged regardless of GSH depletion or not.
However, most of Prx-III was in the oxidized form following inhibition of Trx-2 with
auronofin [25], as AMS did not affect Prx-III mobility (Supplementary Figure 4B). Thus,
GSH plays a critical role in preventing the collateral accumulation of H2O2 following
superoxide scavenging by SOD mimetics.
Mitochondrial peroxynitrite generation requires exogenous NO source and decreases
upon superoxide scavenging
Superoxide can react with NO to yield peroxynitrite. Since uric acid scavenges peroxynitrite
and is produced from xanthine oxidation, we used G/GO to generate superoxide and
examined peroxynitrite with or without GSH depletion. The generation of peroxynitrite in
liver mitochondria, measured by the specific APF probe [22] was negligible unless
supplemented with the NO donor Deta NoNoate (Supplementary Figure 5). Purified SOD
decreased peroxynitrite levels induced by DetaNoNoate and G/GO to a similar extent
regardless of GSH status (Supplementary Figure 5). Thus, mitochondrial peroxynitrite
formation requires an exogenous source of NO and is abolished by superoxide scavenging.
Selective mGSH depletion sensitizes hepatocytes to SOD mimetics-induced cell death
Next, we assessed the effect of SOD mimetics in isolated hepatocytes with mGSH depletion
by HP as described [20, 24]. HP depleted mGSH levels but spared cytosolic GSH (Figure
1E). To stimulate mitochondrial superoxide, hepatocytes were incubated with antimycin A
(AA, 15 M) to block electron transfer at complex III of the MRC [26]. AA increased
von Montfort et al. Page 4
J Hepatol. Author manuscript; available in PMC 2013 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
superoxide generation (Figure 1F). MnTBAP reduced AA-induced superoxide levels and
slightly increased those of H2O2 (Figure 1F, G), with similar findings observed with
CuDIPS (not shown). In mGSH-depleted hepatocytes by HP, MnTBAP reduced the
generation of superoxide induced by AA, but enhanced the formation of H2O2 (Figure 1F,
G). This outcome was associated with sustained activation of the stress kinase JNK,
compared to its transient activation in mGSH-repleted cells (Figure 1H) and with increased
cell death (Figure 1I), characterized by Sytox green staining (Supplementary Figure 6) and
lack of nuclear fragmentation (not shown). Furthermore, HP-mediated sensitization of
hepatocytes to superoxide scavenging was not due to altered mitochondrial protein thiols
using the thiol reactive compound (4-iodobutyl)triphenylphosphonium (not shown), in
agreement with previous observations [24]. Moreover, hepatocytes from MCD fed mice,
which exhibit mGSH depletion and reduced SOD2 activity (see below), exhibited intrinsinc
cell death and were more sensitive to AA than corresponding control hepatocytes (Figure
1J). Similar findings were observed in hepatocytes from MAT1A null mice (not shown).
These findings establish a critical role for mGSH in the safety of superoxide scavenging by
SOD mimetics in hepatocytes.
Protection of hepatocytes against superoxide scavenging following mGSH depletion
Consistent with the lack of caspase activation (Supplementary Figure 7), a pancaspase
inhibitor (caspase inhibitor I, Calbiochem), which prevents Fas and staurosporine induced
cell death, failed to protect mGSH-depleted hepatocytes from AA+MnTBAP exposure
following mGSH depletion (Figure 1I). Moreover, cyclosporine A, which inhibits
mitochondrial membrane permeability transition (MPT), protected against AA+MnTBAP-
mediated killing of hepatocytes following mGSH depletion (Figure 1I). In addition, GSHee,
a permeable GSH form that restores mGSH [24], rescued HP-treated hepatocytes from AA
+MnTBAP-mediated cell death (Figure 1I). Importantly, catalase protected hepatocytes that
have been mGSH depleted either by HP or MCD feeding from AA stimulated cell death
(Figure 1I, J), indicating the involvement of overgeneration of hydrogen peroxide in this
event. Pretreatment with the iron chelator desferoxamine protected mGSH-depleted
hepatocytes against cell death induced by AA+MnTBAP (Figure 1I). Moreover, since RIP1
kinase plays a pivotal role in necrotic cell death, we tested the effect of necrostatin-1, a RIP1
kinase inhibitor [27]. As seen, necrostatin-1 protected mGSH-depleted hepatocytes against
AA+MnTBAP-induced cell death (Figure 1I). Interestingly, necrostatin-1 did not abolish the
sustained JNK activation by MnTBAP in GSH-depleted hepatocytes (Figure 1H), consistent
with previous findings [28]. Moreover, SP600125 a JNK inhibitor failed to protect
hepatocytes against superoxide scavenging following HP sensitization (not shown).
Decreased SOD2 activity in experimental SH
Since the status of SOD2 in NASH is not well established, we examined its expression and
activity in nutritional and genetic NASH models [14, 15]. We chose the MCD feeding
model since although it does not induce insulin resistance it does reproduce key features of
human NASH such as oxidative stress, hepatocellular death, inflammation and fibrosis [15],
which reflects disease progression [29]. For genetic models, we used MAT1A null mice,
which exhibit SH and spontaneous hepatocarcinoma at advanced age [14, 30]. We avoided
the obese ob/ob mice because of the unestablished and controversial status of SOD2 due in
part to altered Mn2+ metabolism [9, 31–33]. While mRNA SOD2 levels increased in both
MCD-fed mice and MAT1A−/− mice (Figure 2), this outcome did not translate in enhanced
SOD2 activity (Figure 2). Samples from mice fed alcohol for 12 months but not 4 weeks
exhibited increased SOD2 expression (Supplementary Figure 8) but decreased activity.
Taken together SOD2 activity is decreased in nutritional and genetic models of SH.
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SOD mimetics exacerbate liver damage in nutritional and genetic SH models
To test the in vivo relevance, we examined the effect of mGSH depletion on superoxide
scavenging in nutritional and genetic SH models [14, 15, 30]. MCD feeding depleted mGSH
levels (Supplementary Figure 9A) by decreasing mitochondrial membrane fluidity [16]. In
MAT1A−/− mice mGSH depletion (Figure 3A) reflects the cytosol GSH limitation due to
decreased SAM levels [14]. Treatment of 3-months old MAT1A mice with MnTBAP (10 g/
mice, i.p) decreased hepatic superoxide but enhanced hydrogen peroxide (Figure 3B, C),
with similar findings in MCD-fed mice (Supplementary Figure 9B). Interestingly, although
SH symptoms occur in MAT1A−/− mice after 3 months of age [14], MnTBAP treatment
enhanced liver damage in the MAT1A−/− mice as revealed by increased ALT release (Figure
3D) and histological analysis (Supplementary Figure 10), with similar findings in MCD-fed
mice (Supplementary Figure 9C, 9D). MnTBAP worsened inflammation (Figure 3E) and
Sirius red staining (Figure 3F) and hydroxyproline (not shown) in 3-months old MAT1A−/−
mice and MCD-fed mice (Supplementary Figure 9E, 9F), without an effect on steatosis
(Supplementary Figure 11A, B). Paralelled to the increased MPO and Sirius red staining in
MCD-fed mice treated with MnTBAP, we observed increased expression of MCP1, IL-1
and TGF- by quantitative PCR analysis (Supplementary Figure 12). Similar findings were
observed in mice fed a HFD for 16–20 weeks following MnTBAP treatment (not shown).
Interestingly, these adverse events induced by MnTBAP occurred despite lower 3-
nitrotyrosine immunohistochemistry in both MAT1A−/− mice (Figure 3G) and MCD-fed
mice (Supplementary Figure 9G). To ensure the oxidant-dependent nature of the preceding
events, we tested the role of mitochondrial-targeted antioxidant MitoQ [34]. In contrast to
decylTPP, in vivo treatment with MitoQ reduced MnTBAP potentiation of MCD-induced
liver injury, fibrosis and inflammation (Supplementary Figure 13). Thus, these findings
underscore that in vivo treatment with the SOD mimetic MnTBAP worsens SH despite
reduced superoxide levels and nitrosative stress.
mGSH replenishment and necrostatin-1 protect MCD-fed mice from liver damage
potentiated by MnTBAP
To address whether the enhanced susceptibility to MnTBAP was due to mGSH depletion,
we compared the therapy of GSHee vs. NAC in MCD-fed mice. GSHee restored the mGSH
levels in MCD-fed mice (Figure 3H). In contrast, while NAC, a GSH precursor, maintained
cytosol GSH it failed to boost the mGSH levels (Figure 3H, I), reflecting the impairment of
mGSH transport induced by MCD [16]. Furthermore, GSHee protected MCD-fed mice from
MnTBAP-induced liver damage revealed by ALT (Figure 3J) and histological analysis (not
shown). Consistent with the findings in GSH compartimentalization, NAC was inefficient in
protecting MCD-fed mice from MnTBAP-mediated liver damage (Figure 3J). Moreover,
necrostatin-1, which protected mGSH-depleted hepatocytes against AA+MnTBAP-induced
cell death, rescued MCD-fed mice against MnTBAP-mediated liver injury (Figure 3K).
Thus, these findings indicate that the worsening by SOD mimetics of nutritional SH is due
largely to mGSH depletion.
Transgenic SOD2 mice exhibit increased susceptibility to MCD-induced steatohepatitis
To validate the preceding findings and to discard unspecific effects of chemical SOD
mimetics, we used TgSOD2 mice to test their susceptibility to MCD. Although the basal
levels of mGSH in wild type and TgSOD2 did not differ (5.8±0.7 and 6.1±0.8 nmol/mg prot,
respectively), MCD feeding depleted mGSH in both mice to a similar extent (42% and 48%
respectively). However, the TgSOD2 mice exhibited more liver injury than wild type mice
upon MCD feeding as seen by serum ALT release (Figure 4A) and H&E imaging (not
shown). Moreover, accompanying these observations, the degree of fibrosis (Figure 4B) and
inflammation (Figure 4C) increased in TgSOD2 mice compared to wild type mice following
MCD feeding. In contrast, 3-nitrotyrosine immunoreactivity, reflecting peroxynitrite
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generation, was lower in TgSOD2 mice with respect to wild type mice after MCD feeding
(Figure 4D). Consistent with the results in MAT1A−/− mice, MCD-fed TgSOD2 mice
exhibited decreased superoxide levels but enhanced hydrogen peroxide levels and were
protected by GSHee treatment (not shown). Thus, these findings show that overexpression
of SOD2 in the face of mGSH depletion sensitizes to nutritional SH.
Discussion
Mitochondrial dysfunction is a prominent feature of SH and contributes to the superoxide
generation and other ROS/RNS species. Here we show that nutritional and genetic models
of SH exhibit decreased SOD2 activity and mGSH depletion. Since the product of SOD2,
H2O2, is the substrate of the GSH redox cycle, we examined the interplay between
superoxide scavenging and mGSH-dependent H2O2 generation in mice fed MCD as well as
MAT1A−/− mice. In addition to SOD2, H2O2 can be also generated from other mechanisms
within mitochondria, including the action of p66Shc, which directly stimulates hydrogen
peroxide generation by transferring electrons to cytochrome c [35]. Thus, mitochondrial
hydrogen peroxide homeostasis reflects the balance between its generation and its reduction,
mainly via the GSH redox cycle. While mGSH depletion in either model occurs via different
mechanisms, including limited cytosol GSH availability and altered mitochondrial
membrane dynamics [16], enhanced SOD2 expression does not correlate with activity.
Decreased SOD2 activity is observed in either model and may reflect sensitivity to
oxidative/nitrosative stress. For instance, SOD2 contains tyrosine residues that are
susceptible to be nitrated or oxidized by peroxynitrite, leading to enzymatic inactivation [36,
37]. Consistent with impaired SOD2 activity, both models show enhanced basal levels of
superoxide. Since superoxide can react with NO to form peroxynitrite, a reactive nitrogen
species responsible for mitochondrial dysfunction [8], the use of SOD mimetics would
imply a dual benefit, diminishing both superoxide and peroxynitrite. Contrary to these
expectations, superoxide scavenging sensitized hepatocytes to oxidant-dependent necrosis
following mGSH depletion due to increased H2O2. The toxic effect of enhanced H2O2 could
be due to the generation of hydroxyl radical via Fenton reaction (Figure 4E) and the
induction of MPT by targeting critical cysteine resides in cyclophilin D [38]. Consistent
with these possibilities, the iron chelator desferoxamine or cyclosporine A protected mGSH-
depleted hepatocytes against superoxide anion scavenging. Moreover, treatment with
MnTBAP of both MCD-fed mice and 3-months old MAT1A−/− mice, which does not yet
exhibit signs of SH [14], increased and accelerated signs of disease progression
(hepatocellular damage, inflammation and fibrosis) despite reducing superoxide and 3-
nitrotyrosine immunoreactivity. While these effects were mitigated by recovery of the
mGSH store by GSHee, NAC failed to recover the mGSH pool and to protect both models
against MnTBAP-enhanced pathology. Our findings are consistent with previous reports
defining a critical role for mGSH in the control of stimulated H2O2 generation in the MRC
[26, 39]. Low levels of mGSH depletion (up to 40%) had little effect on H2O2 diffusion
from mitochondria. However, GSH depletion below a critical threshold (about 50%) results
in a linear increase in H2O2 production from mitochondria, which compromises cell
viability and mitochondrial function [26, 39].
Chemical SOD mimetics have been developed and characterized for SOD activity [12, 13].
In particular the anionic porphyrin MnTBAP has been shown to exhibit scavenging activity
towards superoxide anion and peroxynitrite [40]. While MnTBAP was inefficient in
supporting the aerobic growth of SOD-deficient E. coli [40], however studies in Sod2tm1Cje
null mice demonstrated the therapeutic benefit of MnTBAP administration, including
prevention of systemic pathology such as dilated cardiomyopathy, hepatic lipid
accumulation, and most importantly, a dramatically extended lifespan [41]. Thus, these data
with the SOD2 null mice indicate that this particular SOD mimetic can functionally
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overcome SOD2 deficiency. Regardless of whether MnTBAP is specific for scavenging
superoxide anion or peroxynitrite, since the latter derives from the former upon reaction
with NO, the elimination of superoxide anion will invariably result in decreased
peroxynitrite as well. Moreover, our findings with MnTBAP in isolated mitochondria were
validated with purified SOD. More importantly, the increased susceptiblity of TgSOD2 mice
to MCD-induced liver injury, inflammation and fibrosis provide compelling evidence for the
deleterious effects of superoxide scavenging in the face of mGSH depletion.
Our findings have potential clinical implications as they may help explain the failure of
antioxidant treatment so far in human liver diseases. Data and models described here could
offer an explanation for the important discrepancy between the overwhelming evidence for
an important role of ROS and the common clinical failure of trials. Thus, this study indicates
that a better approach to treat SH is the combination of SOD mimics with mGSH restoration
rather than improving only SOD2 with SOD mimetics, illustrating the importance of a
delicate equilibrium between these two antioxidants to ensure protection and therapeutic
benefit.
Supplementary Material
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ABBREVIATIONS
ASH alcoholic steatohepatitis
AA antimycin A
HP 3-hydroxy-4-pentenoate
GSHee GSH ethyl ester
GSHPx1 GSH peroxidase 1
mGSH mitochondrial GSH
MCD methionine-choline deficient diet
MRC mitochondrial respiratory chain
NAC N-acetylcysteine
NASH nonalcoholic steatohepatitis
SH steatohepatitis
Prx-III peroxiredoxin-III
SOD superoxide dismutase
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ROS reactive oxgen species
RNS reactive nitrogen species
Trx2 thioredoxin-2.
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Figure 1. Effect of MnTBAP on isolated rat liver mitochondria with or without GSH depletion
and sensitization of mGSH-depleted hepatocytes to SOD mimetic-induced necrotic cell death
A, GSH levels after EA incubation; *p<0.05 vs control. B–C, ROS determination by
MitoSOX and Amplex Red. Both MitoSOX and Amples Red measurements were done after
10 min of incubation; B, * p<0.05 vs. control; # p<0.05 vs X+XO; **p<0.05 vs X+XO; #
p<0.05 vs EA+X+XO; C, *p<0.05 vs control; **p<0.05 vs EA+X/XO; #p<0.05 vs EA+X/
XP+MnTBAP. D, redox status of Prx-III in the presence or absence of AMS. tBOOH was
used as a positive control to induce the oxidation of Prx-III. Data are the mean±SD of 10–12
mitochondrial preparations. E, GSH in cytosol and mitochondria from rat hepatocytes
incubated with HP. *p<0.05 vs. control. E–G, ROS determination as in Fig 1B–C following
von Montfort et al. Page 12
J Hepatol. Author manuscript; available in PMC 2013 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
incubation with or without AA, HP or MnTBAP; B, *p<0.05 vs. control; **p<0.05 vs. AA;
# p<0.05 vs. AA; ## p<0.05 vs. HP+AA; C, *p<0.05 vs. control; ** p<0.05 vs. HP+AA. H,
Effect of mGSH depletion on the time-dependent JNK phosphorylation after incubation with
AA, MnTBAP or necrostatin-1. A representative western blot of 6 individual experiments is
shown. I, hepatocellular death determined by Trypan blue and effect of different inhibitors.
*p<0.05 vs control; # p<0.05 vs. AA with or without HP; ** p<0.05 vs HP+AA; ## p<0.05
vs. HP+AA+MnTBAP. J, cell death of hepatocytes isolated from MCD-fed mice with or
without exposure to AA and effect of catalase defense. *p<0.05 vs control hepatocytes;
**p<0.05 vs. MCD hepatocytes. Data are the mean± SD of 12–14 individual cell
preparations.
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Figure 2. SOD2 expression and activity in experimental models
A–B, liver samples from MAT1A KO mice were processed for SOD2 expression (A) and
activity (B); *p<0.05 vs control. C–D, liver samples from mice fed MCD diet were
processed for SOD2 expression (C) and activity (D); *p<0.05 vs. control. *p<0.05 vs
control. Data are the mean±SD of 5–6 samples.
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Figure 3. MnTBAP treatment in vivo increases liver injury in MAT1A knockout mice and
combination therapy in MCD-fed mice
A, liver mitochondrial GSH from wild type (WT) and MAT1A null mice. B, MitoSOX and
C, Amplex Red measurement of liver samples from WT and MAT1A null mice with or
without MnTBAP treatment. D, serum ALT levels in WT and MAT1A null mice with or
without in vivo treatment with MnTBAP. Representative images of myeloperoxidase, MPO
(E), Sirius red (F), and 3-nitrotyrosine immunoreactivity (G) of MAT1A null mice upon
MnTBAP treatment. Data are representative images of experiments from 5–6 individual
mice.*p<0.05 vs. WT and MAT1A null mice; #p<0.05 vs. MAT1A−/− mice. H-I, hepatic
mitochondrial GSH (H) or cytosol GSH (I) from MCD-fed mice with or without in vivo
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treatment with NAC or GSHee; *p<0.05 vs control; #p<0.05 vs. MCD. J–K, serum ALT
levels from MCD fed mice following treatment with MnTBAP, NAC, GSHee or
necrostatin-1 (Nec-1) as indicated; *p<0.05 vs. control; **p<0.05 vs MCD; #p<0.05 vs.
MCD+MnTBAP;##p<0.05 vs. MCD+MnTBAP. Data are the mean± SD of 4–6 individual
mice.
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Figure 4. TgSOD2 mice exhibit increased susceptibility to MCD-induced SH
A, serum ALT levels from wild type mice or TgSOD2 mice fed MCD; *p<0.05 vs. WT;
**p<0.05 vs. WT+MCD. B, Sirius red staining of liver sections from wild type mice or
TgSOD2 mice fed MCD diet. Data are the mean±SD of 3–4 mice. C, myeloperoxidase
staining of liver samples from wild type mice or TgSOD2 mice fed MCD diet. D, 3-
nitrotyrosine immunoreactivity of wild type mice and TgSOD2 mice fed MCD diet. E,
schematic diagram illustrating the effects of superoxide scavenging by SOD mimics with or
without GSH depletion.
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